SF3B14 and SFPQ showed upregulation in patients with CD but not in those with UC, indicating that the splicing factor expression levels of UC and CD are different and play different roles in different disease subtypes, suggesting that a mechanism of this aspect may serve as a diagnostic marker for IBD in the future. Here, SFPQ is linked to inflammatory bowel disease.